Anti-ALPP CAR-T Cells Immunotherapy for Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
A Study of MEDI9253 in Combination With Durvalumab in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With BinTrafusp Alfa (M7824 or TGF-beta "Trap"/PD-L1) With CV301 TRICOM in Advanced Solid Tumors (STAT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
- Status
- COMPLETED
- Phase
- N/A
Machine Learning to Analyze Facial Imaging, Voice and Spoken Language for the Capture and Classification of Cancer/Tumor Pain
- Status
- COMPLETED
- Phase
- N/A
A Study of DF6002 Alone and in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
- Status
- SUSPENDED
- Phase
- PHASE1
A Study of TAK-102 in Adult With Previously-Treated Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study Of The Pharmacokinetics And Safety Of Ipatasertib In Chinese Participants With Locally Advanced Or Metastatic Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
A Study of RC98 in Subjects With Advanced Malignant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the Body
- Status
- COMPLETED
- Phase
- PHASE1
Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2